Guanghui Zheng

capital medical university

H指数:18

被引数:978

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Serum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center Validation

血清SERPINA3作为视神经脊髓炎谱系障碍的非侵入性生物标志物候选物：蛋白质组学发现及同中心验证

Diagnostics

IF3.3

2026-08-300

The FaDOF1.7-FaDOF1.5 module orchestrates soluble sugar accumulation in strawberry fruit

FaDOF1.7-FaDOF1.5模块调控草莓果实中可溶性糖的积累

The Plant Journal

IF0

2026-05-210

PRE

The Gα protein FveGPA1 regulates inflorescence architecture via the FveBRI1-mediated brassinosteroid pathway in strawberry

FveGPA1 Gα蛋白通过FveBRI1介导的油菜素内酯途径调控草莓花序结构

The Plant Cell

IF0

2026-05-010

PRE

The MicroRNA156a-SPL module regulates kiwifruit resistance to Pseudomonas syringae pv. actinidiae

MicroRNA156a-SPL模块调控猕猴桃对Pseudomonas syringae pv. actinidiae的抗性

The Plant Journal

IF0

2026-03-040

PRE

FaMYB63 and FvWYRKY75 Activate FvPR10.14 Boosting Strawberry Immunity Against Powdery Mildew

FaMYB63和FvWYRKY75激活FvPR10.14，增强草莓对白粉病的抗性。

MOLECULAR PLANT PATHOLOGY

IF4.9

2025-12-080

OAAI

FaMADS6 negatively regulates anthocyanin accumulation in strawberry by inhibiting FaMYB10 expression and ABA biosynthesis

FaMADS6通过抑制FaMYB10表达和ABA生物合成，负调控草莓中花青素的积累。

Horticultural Plant Journal

IF6.2

2025-05-090

OAAI

The DOF transcription factor, FaDOF1 affects eugenol accumulation in strawberry

PLANT GROWTH REGULATION

IF3.9

2024-09-090

PRE

Pembrolizumab in combination with low-dose cisplatin/5-fluorouracil for neoadjuvant chemoimmunotherapy of locally advanced head and neck squamous cell carcinoma: A single-arm clinical trial

帕博利珠单抗联合低剂量顺铂/5-氟尿嘧啶用于局部晚期头颈部鳞状细胞癌新辅助化免疫治疗的单臂临床试验

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction

MOLECULAR MEDICINE

IF6.4

2024-06-151

OAAI

Overexpression of transcription factor FaMYB63 enhances salt tolerance by directly binding to the SOS1 promoter in Arabidopsis thaliana

PLANT MOLECULAR BIOLOGY

IF3.8

2024-03-217

PRE

Insufficiency of plasmatic arginine/homoarginine during the initial postoperative phase among patients with tumors affecting the medulla oblongata heightens the likelihood of neurogenic pulmonary oedema following surgery

INTERNATIONAL JOURNAL OF SURGERY

IF10.1

2024-03-010

OAAI

ATP-binding cassette protein ABCC8 promotes anthocyanin accumulation in strawberry fruits

ATP结合盒蛋白ABCC8促进草莓果实花青素积累

PLANT PHYSIOLOGY AND BIOCHEMISTRY

IF5.7

2023-10-015

PRE

Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2023-04-278

OAAI

Diagnostic Potential of Two Novel Biomarkers for Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis

DIAGNOSTICS

IF3.3

2023-04-270

OAAI

Protective properties of extracellular vesicles in sepsis models: a systematic review and meta-analysis of preclinical studies

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2023-04-179

OAAI

The monoacylglycerol lipase inhibitor, JZL184, has comparable effects to therapeutic hypothermia, attenuating global cerebral injury in a rat model of cardiac arrest

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-12-014

OAAI

Factor of DNA methylation 1 affects woodland strawberry plant stature and organ size via DNA methylation

PLANT PHYSIOLOGY

IF6.9

2022-10-0613

Necrosulfonamide improves post-resuscitation myocardial dysfunction via inhibiting pyroptosis and necroptosis in a rat model of cardiac arrest

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2022-07-0112

PRE

Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironmemt

STEM CELL RESEARCH & THERAPY

IF7.3

2022-01-2810

OAAI

The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation

CARDIOVASCULAR DRUGS AND THERAPY

IF3.1

2022-01-0110

OAAI

Guanghui Zheng

个人简介

教育背景

工作经历

荣誉奖项

研究方向